Correction to: Eye (2015) 29, 342–349; doi:10.1038/eye.2014.258; published online 7 November 2014
Since the online publication of the above article, the authors have noted that Figure 3 is incorrect. Interval increased has been repeated and the wording below the diagonal line should be interval decreased. The corrected figure can be found below.
The authors would like to apologise for this error.
The online version of the original article can be found at 10.1038/eye.2014.258
Rights and permissions
About this article
Cite this article
Gianniou, C., Dirani, A., Ferrini, W. et al. Erratum: Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration: how to alleviate the clinical burden with maintained functional results. Eye 29, 450–451 (2015). https://doi.org/10.1038/eye.2014.321
This article is cited by
Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration treated with Aflibercept
Graefe's Archive for Clinical and Experimental Ophthalmology (2017)
The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study
BMC Ophthalmology (2016)
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
Drugs & Aging (2015)